International Paper Company (NYSE:IP) shares advanced 2.97% in last trading session and ended the day at $42.94. IP Gross Margin is 31.20% and its has a return on assets of 3.60%. International Paper Company (NYSE:IP) quarterly performance is -14.01%.
International Paper Company is a paper and packaging company with primary markets and manufacturing operations in North America, Europe, Latin America, Russia, Asia, Africa and the Middle East. The Company operates in three segments: Industrial Packaging, Printing Papers and Consumer Packaging. Industrial Packaging segment’s products include linerboard, medium, whitetop, recycled linerboard, recycled medium and saturating kraft.
On 25 August, International Paper Company (NYSE:IP) and National Fish and Wildlife Foundation (NFWF) announced $2.1 million in grants to support forestland restoration and working forests in three priority regions in the Southeast: The Carolina Low Country Forests; Cumberland Plateau of Alabama, Georgia, Kentucky and Tennessee; and the Piney Woods of Texas and Louisiana. Thirteen projects have been selected to receive grants through the Forestland Stewards Initiative, a partnership of NFWF and International Paper.
National Oilwell Varco, Inc. (NYSE:NOV) ended the last trading day at $40.62. Company weekly volatility is calculated as 3.21% and price to cash ratio as 6.13. National Oilwell Varco, Inc. (NYSE:NOV) showed a weekly performance of -4.04%.
National Oilwell Varco, Inc. (NOV) is engaged in providing design, manufacture and sale of equipment and components used in oil and gas drilling, completion and production operations. The Company also provides oilfield services to the upstream oil and gas industry. The Company operates through four segments: Rig Systems, Rig Aftermarket, Wellbore Technologies, and Completion & Production Solutions. Its Rig Systems segment makes and supports the capital equipment and integrated systems needed to drill oil and gas wells on land and offshore.
National Oilwell Varco, Inc. (NYSE:NOV) announced a cash dividend payment of $0.46 per share is scheduled to be paid on September 25, 2015. Shareholders who purchased NOV prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 6th quarter that NOV has paid the same dividend. At the current stock price of $40.44, the dividend yield is 4.55%.
On 08 September, Nacco Industries Inc. (NYSE:NC) shares advanced 0.86% and was closed at $53.65. NC EPS growth in last 5 year was -47.20%. Nacco Industries Inc. (NYSE:NC) year to date (YTD) performance is -8.34%.
NACCO Industries, Inc. is a holding company. The Company’s subsidiaries operate in principal businesses, including mining, small appliances and specialty retail. The Company’s principal wholly owned subsidiaries include The North American Coal Corporation (NACoal), Hamilton Beach Brands, Inc. (HBB) and Kitchen Collection (KC). NACoal mines and markets steam and metallurgical coal for use in power generation and steel production and provides mining services for other natural resources companies. HBB is a designer, marketer and distributor of small electric household appliances, as well as commercial products for restaurants, bars and hotels. KC is a specialty retailer of kitchenware and gourmet foods.
Nacco Industries Inc. (NYSE:NC) announced that the Board of Directors declared a regular cash dividend of 26.25 cents per share. The dividend is payable on both the Class A and Class B Common Stock, and will be paid September 15, 2015 to stockholders of record at the close of business on September 1, 2015.
BioTime, Inc. (NYSEMKT:BTX) shares advanced 13.98% in last trading session and ended the day at $3.67. BTX Gross Margin is 84.10% and its has a return on assets of -55.60%. BioTime, Inc. (NYSEMKT:BTX) quarterly performance is -8.93%.
BioTime, Inc. is a biotechnology company. The Company is focused on the field of regenerative medicine; human embryonic stem (hES) cell and induced pluripotent stem (iPS) cell technology. Regenerative medicine refers to therapies based on stem cell technology that are designed to rebuild cell and tissue function lost due to degenerative disease or injury. hES and iPS cells provide a means of manufacturing every cell type in the human body.
On 4 September, BioTime, Inc. (NYSEMKT:BTX) announced that the Tel Aviv Stock Exchange (TASE) has approved the new listing of BioTime’s common shares beginning on Tuesday, September 8, 2015 under the ticker symbol BTX. Based on the current market capitalization, BioTime’s shares are anticipated to be included in five TASE equity indexes: TASE’s TA-75, TA-100, TA-BlueTech, TA-Tech-Elite and TA-Biomed.
CTI BioPharma Corp. (NASDAQ:CTIC) caters to the Healthcare space. On the last day of trading company shares ended up $1.58. CTI BioPharma Corp. (NASDAQ:CTIC) distance from 50-day simple moving average (SMA50) is -12.57%.
CTI BioPharma Corp. (CTI), formerly Cell Therapeutics, Inc., is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers. The Company is focused on commercializing PIXUVRI (pixantrone), or PIXUVRI, in the European Union, for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (NHL), and conducting a Phase III clinical trial program of pacritinib for the treatment of adult patients with myelofibrosis to support regulatory submission for approval in the United States and Europe. It is also engaged in evaluating pacritinib in earlier clinical trials as treatment for other blood-related cancers. Its development product candidates include to sedostat and Opaxio.
Roth Capital reiterated their buy rating on shares of CTI BioPharma Corp. (NASDAQ:CTIC) in a resaerch note published on Friday, AnalystRatings.NET reports. Roth Capital currently has a $4.50 price target on the biopharmaceutical company’s stock.
Leave a Reply